Summary of Product Characteristics
last updated on the eMC:
05/03/2008
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 05/03/2008 and displayed until Current
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 27/07/2007 and displayed until 05/03/2008
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 05/2007 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
Section 7.1 Change to the MAH address
Section 10 Change in the date of revision
|
|
Updated on 12/03/2003 and displayed until 27/07/2007
|
Reasons for adding or updating:
|
-
Change to section 4.1 - Therapeutic Indications
|
|
Updated on 29/05/2002 and displayed until 12/03/2003
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 8 - MA number
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 04/03/2002 and displayed until 29/05/2002
|
Reasons for adding or updating:
|
-
Change to section 4.4 - Special Warnings and Precautions for Use
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 23/08/2001 and displayed until 04/03/2002
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 01/08/2001 and displayed until 23/08/2001
|
Reasons for adding or updating:
|
-
Change to section 4.3 - Contra-indications
-
Change to section 4.4 - Special Warnings and Precautions for Use
|
|
Updated on 19/09/2000 and displayed until 01/08/2001
|
Reasons for adding or updating:
|
|
|
|
Updated on 06/09/1999 and displayed until 19/09/2000
|
Reasons for adding or updating:
|
|
|
|